Video News June 20, 2021Three FDA members resign over Biogen's Alzheimer drug approval: RPT 0 0 Share
Video News June 20, 2021Cramer on FDA resignations in connection with approval of Biogen's Alzheimer's drug 0 0 Share
Video News June 20, 2021Eli Lilly CEO discusses FDA's approval of Biogen's new Alzheimer's drug 0 0 Share
Company Ticker News June 20, 2021Alzheimer's Approval Validates Biopharmaceutical Innovation 0 0 Share
Company Ticker News June 17, 2021Biogen (BIIB) Ends Development of Anti-Tau Alzheimer's Drug 0 0 Share
Press Release June 17, 2021Biogen Commences Dosing In Late-Stage Systemic Lupus Erythematosus Study With BIIB059 0 0 Share
